FindTrial
Sign In

Quality of life and drug therapy management in women with PCOS

ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE AND DRUG THERAPY MANAGEMENT FOR WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/040243
Enrollment
137
Registered
2022-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N948- Other specified conditions associated with female genital organs and menstrual cycle

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Out-patients of Department of Obstetrics & Gynaecology and IVF Center Kshema, Department of Endocrinology, Department of Dermatology. Women aged 15-45 years, Patients with physical symptoms of PCOS, Women with biochemical abnormalities or polycystic ovaries visualized in ultra sound, Patients who are willing to participate in the study.

Exclusion criteria

Exclusion criteria: Women who are not willing to Participate, Patients who provide incomplete information.

Design outcomes

Primary

MeasureTime frame
The study aims to learn the upcoming need for specific, overall and multimode treatment provided by practitioners from different disciplines.Timepoint: Date of Hospital Visit.—

Secondary

MeasureTime frame
To assess the influence of PCOS on HRQoL.Timepoint: Date of Hospital Visit.—

Countries

India

Contacts

Public ContactDr Supriya Rai

NGSM Institute Of Pharmaceutical Sciences

junojoel@nitte.edu.in9480470727

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026